Jco Global Oncology
Overview
Jco Global Oncology is a scientific journal, published since 2019 in English. The journal's country of origin is United States and its primary focus area is oncology.
Details
Details
Abbr.
JCO Glob Oncol
Start
2019
End
Continuing
Frequency
Annual
e-ISSN
2687-8941
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 8879
39
SJR / Ranks: 3069
1138
CiteScore / Ranks: 3928
5.90
Recent Articles
1.
Abioye O, Kaufman R, Greten T, Monge C
JCO Glob Oncol
. 2025 Mar;
11:e2400537.
PMID: 40080751
Cancer disparities are well-established across measures of cancer incidence and mortality. Cholangiocarcinoma, a common hepatic malignancy, is no exception to these inequities. Globally and within the United States, Asian, Hispanic,...
2.
3.
Cha J, Dickson J, Mfura H, Bondarchuk C
JCO Glob Oncol
. 2025 Mar;
11:e2400466.
PMID: 40080749
No abstract available.
4.
Khowaja M, Ahmad A, Altaf S, Anwar S, Faizan M, Ghafoor T, et al.
JCO Glob Oncol
. 2025 Mar;
11:e2400443.
PMID: 40080748
Purpose: Utilization of clinical research methodology as a means for improvement in pediatric cancer outcomes is well established. Toward achievement of its WHO-Global Initiative for Childhood Cancer (GICC) goals in...
5.
Combariza-Vallejo J, Orduz-Rodriguez R, Gomez-Lopera N, Colmenares-Mejia C, Benavides-Rojas M, Calderon-Ortega Y, et al.
JCO Glob Oncol
. 2025 Mar;
11:e2400495.
PMID: 40080747
Purpose: Marginal zone lymphomas (MZLs) are indolent non-Hodgkin lymphomas, categorized into three subtypes: extranodal, splenic, and nodal MZL (NMZL). MZL epidemiology and outcomes in Latin America remain underexplored. Materials And...
6.
Kumar P, Metzger M, Choi J, Job G, Santiago T, Pena A, et al.
JCO Glob Oncol
. 2025 Mar;
11:e2400491.
PMID: 40053902
Purpose: Clinical and histopathologic diagnosis of pediatric mature B-cell lymphomas (eg, Burkitt lymphoma [BL]) must be accurate to select appropriate risk-based treatment. The Central American Pediatric Hematology-Oncology Association (AHOPCA) in...
7.
Souza A, Barrios C, de Jesus R, Reinert T, Giacomazzi J, Rosa D, et al.
JCO Glob Oncol
. 2025 Mar;
11:e2400337.
PMID: 40053901
Purpose: Low rates of germline genetic testing (GGT) for breast cancer (BC) have been reported globally, with limited data from low- and middle-income countries (LMICs). In this study, we used...
8.
Fang M, Gico V, Casimiro L, Takatsu B, Neto E, Mendoza Lopez R, et al.
JCO Glob Oncol
. 2025 Mar;
11:e2400277.
PMID: 40053900
Purpose: To evaluate the toxicity profile and efficacy of postoperative ultra-hypofractionated radiation therapy in elderly patients with breast cancer. Materials And Methods: This is a nonrandomized, single-center, prospective Phase II...
9.
Jain H, Eipe T, Shetty A, Nayak L, Bagal B, Sharma N, et al.
JCO Glob Oncol
. 2025 Mar;
11:e2400482.
PMID: 40053899
Purpose: Over the past decade, there have been significant advancements in the treatment of AML. However, similar progress has not been observed in India, with induction mortality rates surpassing those...
10.
Acevedo K, Soto G, Shapiro M, Foster J, Valverde K, Schafer E, et al.
JCO Glob Oncol
. 2025 Mar;
11:e2400450.
PMID: 40053898
Purpose: Infusions of high-dose methotrexate at 5 g/m over 24 (HDMTX) as a single infusion for pediatric patients with high-risk precursor B-cell ALL are known to lead to superior outcomes....